As former CEO of Seattle biotech DendreonCorp. Mitchell Gold embarks on a new biotech immunotherapy…
adminApril 17, 2015
He’s launching a next-generation immunotherapy startup called Alpine Immune Sciences, seeding about $1.3 million into the company…
adminFebruary 1, 2015
Seattle biotechnology company Oncothyreon has acquired another local firm, Alpine Biosciences, for about $27 million…
adminAugust 17, 2014
Seattle-based oncology company Oncothyreon Inc. has acquired Alpine Biosciences, a Seattle-based biotechnology company developing what are…
adminAugust 17, 2014
Oncothyreon to Leverage Alpine's Protocell Technology to Enable Targeted Delivery of Molecular Therapeutics for Serious…
adminAugust 2, 2014
A joint technology developed at the University of New Mexico and Sandia National Labs that…
adminDecember 13, 2013
Dr. Mitchell H. Gold, a nationally recognized pioneer in emerging cancer-fighting therapies, is throwing his…
adminDecember 9, 2013
Former Dendreon CEO Mitch Gold has partnered with biotechnology stock researcher David Miller to create…
adminSeptember 3, 2013